
29-01-2020 Print
American regulator the US Food and Drug Administration has issued warning letters to India’s top drug…
To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
Dr Reddy's LaboratoriesFocus OnFrom our correspondentGenericsGlenmark PharmaceuticalsGlenmark Pharmaceuticals LtdIn DepthIndiaLupinProductionRegulationUS FDAUSA



